Purchase Order 75N91020P00165

<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $5,549.00 on April 16, 2018, with final completion on May 12, 2018. No set-aside was used. The order covers software licensing—specifically Qlucore Omics Explorer, the vendor's data analysis platform for genomics and cancer research. Performance is at Bethesda, Maryland.</p>

<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $4,624.00 on March 13, 2018, with ultimate completion on April 13, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order procures scientific software licensing, specifically Qlucore Omics Explorer for data visualization and analysis in genomics and cancer research applications.</p>

<p>Qlucore Inc. has been awarded a $23,600 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software. The contract has no set-aside designation and runs through January 23, 2025. Performance will take place in New York, New York to support the National Cancer Institute's research programs.</p>

This is a federal contract award to Qlucore Inc., a foreign-owned, for-profit organization, by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services. The contract provides Qlucore's Qlucore Omics Explorer software, including four academic floating licenses (four concurrent users) and one next-generation sequencing (NGS) add-on floating license. The total ceiling value of the contract is $21,860.00, and it is a firm-fixed-price purchase order....

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qlucore Inc. for $13,738.00 on August 23, 2019. The order, firm fixed price with no set-aside, covers Qlucore Omics Explorer software. Performance is located in New York, New York, with completion by August 31, 2020. The purchase order funds software licensing for research and data analysis purposes.</p>

This is a firm fixed-price purchase order award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Qlucore Inc., a foreign-owned, for-profit corporation. The award is for an academic floating license of Qlucore's Omics Explorer software, a data analysis tool used in research on fields such as genomics, cancer, infectious diseases, and aging. The contract has a ceiling value of $5,549.00 and an...

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for a QCI subscription valued at $24,000.00 on December 17, 2019, with ultimate completion on July 1, 2020. Place of performance is Germantown, Maryland. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute issued a purchase order to Qiagen, LLC on December 18, 2020, for scientific equipment valued at $24,984.12, with completion required by January 31, 2021. Performance takes place in Germantown, Maryland. The order is priced on a firm fixed price basis.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $11,414.00 on March 20, 2018, with an ultimate completion date of April 20, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order is a firm fixed price commercial transaction. The specific commodity or service being procured is not detailed in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480 on June 9, 2020, with an ultimate completion date of June 14, 2021. Work is performed in Germantown, Maryland. The order is firm fixed price with no set-aside category. No additional source material specifies the scope of services or supplies procured under this purchase order.</p>